Gene replacement, antisense drugs and other genetic therapies have turned some inherited neuromuscular diseases from untreatable into manageable conditions. Neurologists now need to know who qualifies, how treatment is given and what follow-up looks like, and this category follows that change with two courses so far.The Penn Medicine Neuromuscular Symposium 2026 from the University of Pennsylvania is the most focused choice for neuromuscular disease. Harvard Front Line Neurology: Advances and Innovations 2026 from Harvard Medical School gives a wider update on new developments across neurology, useful for placing genetic treatment beside other advances.Neurologists, neuromuscular fellows, pediatric neurologists and rehabilitation physicians will get the most from these recordings. Each title here goes out by fast Google Drive delivery, and its lifetime download link is there for watching again as new therapies reach the clinic.
